CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis

Overview of attention for article published in Blood, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 4 news outlets
twitter: 9 X users

patent: 1 patent

Readers on

mendeley: 37 Mendeley

Summary News X Patents

So far, Altmetric has seen 4 news stories from 4 outlets.

Promising approach for prognosis and treatment in mastocytosis

Today Topics , 14 Dec 2016

Systemic mastocytosis is a rare, incurable disease that affects approximately one in every 10,000 people.

Promising approach for prognosis and treatment in mastocytosis

Medical News Today, 14 Dec 2016

Systemic mastocytosis is a rare, incurable disease that affects approximately one in every 10,000 people.

Promising approach for prognosis and treatment in mastocytosis

MedicalXpress, 13 Dec 2016

Systemic mastocytosis is a rare, incurable disease that affects approximately one in 10,000 people.

Promising approach for prognosis and treatment in mastocytosis

AlphaGalileo, 13 Dec 2016

Printer friendly versionShare 13 December 2016 Medical University of Vienna Systemic mastocytosis is a rare, incurable disease…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.